Anthony G. Quinn - Net Worth and Insider Trading
Anthony G. Quinn Net Worth
The estimated net worth of Anthony G. Quinn is at least $2 Million dollars as of 2024-06-09. Anthony G. Quinn is the President & CEO of Spyre Therapeutics Inc and owns about 32,673 shares of Spyre Therapeutics Inc (SYRE) stock worth over $1 Million. Anthony G. Quinn is also the Director of Generation Bio Co and owns about 161,332 shares of Generation Bio Co (GBIO) stock worth over $525,942. Details can be seen in Anthony G. Quinn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony G. Quinn has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).
Transaction Summary of Anthony G. Quinn
Anthony G. Quinn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony G. Quinn owns 3 companies in total, including Kaleido Biosciences Inc (KLDO) , Generation Bio Co (GBIO) , and Spyre Therapeutics Inc (SYRE) .
Click here to see the complete history of Anthony G. Quinn’s form 4 insider trades.
Insider Ownership Summary of Anthony G. Quinn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KLDO | Kaleido Biosciences Inc | 2019-02-27 | director |
| GBIO | Generation Bio Co | 2023-12-01 | director |
| SYRE | Spyre Therapeutics Inc | 2022-03-16 | director |
Anthony G. Quinn Latest Holdings Summary
Anthony G. Quinn currently owns a total of 2 stocks. Among these stocks, Anthony G. Quinn owns 32,673 shares of Spyre Therapeutics Inc (SYRE) as of March 16, 2022, with a value of $1 Million and a weighting of 67.66%. Anthony G. Quinn also owns 161,332 shares of Generation Bio Co (GBIO) as of December 1, 2023, with a value of $525,942 and a weighting of 32.34%.
Latest Holdings of Anthony G. Quinn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2022-03-16 | 32,673 | 33.67 | 1,100,100 |
| GBIO | Generation Bio Co | 2023-12-01 | 161,332 | 3.26 | 525,942 |
Holding Weightings of Anthony G. Quinn
Anthony G. Quinn Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony G. Quinn has made a total of 5 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Spyre Therapeutics Inc is the acquisition of 3,203 shares on March 16, 2022, which cost Anthony G. Quinn around $187,385.
According to the SEC Form 4 filings, Anthony G. Quinn has made a total of 1 transactions in Generation Bio Co (GBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Generation Bio Co is the acquisition of 88,495 shares on December 1, 2023, which cost Anthony G. Quinn around $124,778.
Insider Trading History of Anthony G. Quinn
- 1
Anthony G. Quinn Trading Performance
GuruFocus tracks the stock performance after each of Anthony G. Quinn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony G. Quinn is 3.49%. GuruFocus also compares Anthony G. Quinn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony G. Quinn within 3 months outperforms 6 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anthony G. Quinn's insider trading performs compared to the benchmark.
Performance of Anthony G. Quinn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.59 | | | | | |
| Relative Return to S&P 500(%) | -1 | | | | | |
Anthony G. Quinn Ownership Network
Anthony G. Quinn Owned Company Details
What does Kaleido Biosciences Inc do?
Who are the key executives at Kaleido Biosciences Inc?
Anthony G. Quinn is the director of Kaleido Biosciences Inc. Other key executives at Kaleido Biosciences Inc include Chief Medical Officer Alison S Long , Chief Scientific Officer Van Hylckama Vlieg Johan , and director & Chief Executive Officer Daniel L Menichella .
Kaleido Biosciences Inc (KLDO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kaleido Biosciences Inc Insider Transactions
Anthony G. Quinn Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony G. Quinn. You might contact Anthony G. Quinn via mailing address: C/o Aeglea Biotherapeutics, Inc., 901 S. Mopac Expwy, Ste. 250, Austin Tx 78746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
